Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

NCT00002855 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

306

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Bicalutamide
DRUG: Doxorubicin hydrochloride
DRUG: Estramustine Phosphate Sodium
DRUG: Flutamide
DRUG: Ketoconazole
DRUG: Nilutamide
DRUG: Therapeutic Hydrocortisone
DRUG: Vinblastine
PROCEDURE: Conventional Surgery

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]